Rodrigo Gil-Manso
A5049682231- COVID-19 and healthcare impacts
- COVID-19 Clinical Research Studies
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Childhood Cancer Survivors' Quality of Life
- Economic and Financial Impacts of Cancer
- Acute Myeloid Leukemia Research
- SARS-CoV-2 and COVID-19 Research
- Cardiovascular and Diving-Related Complications
- Cardiovascular Syncope and Autonomic Disorders
- Healthcare cost, quality, practices
- Hemoglobinopathies and Related Disorders
- Traumatic Brain Injury and Neurovascular Disturbances
- Lung Cancer Treatments and Mutations
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
Research Institute Hospital 12 de Octubre
2021-2024
Hospital Universitario 12 De Octubre
2020-2024
Instituto de Salud Carlos III
2020-2024
Centro de Investigación Biomédica en Red de Cáncer
2020-2024
Universidad Complutense de Madrid
2024
Spanish National Cancer Research Centre
2023-2024
Centro de Investigación Biomédica en Red
2023
Abstract Background Patients with cancer have been shown to a higher risk of clinical severity and mortality compared non-cancer patients COVID-19. hematologic malignancies typically are known levels immunosuppression may develop more severe respiratory viral infections than solid tumors. Data on COVID-19 in limited. Here we characterize disease evaluate potential prognostic factors for mortality. Methods In this population-based registry study, collected de-identified data characteristics,...
Chronic neutrophilic leukemia (CNL) and atypical chronic myeloid (aCML) are rare disorders that challenging with regard to diagnosis clinical management. To study the similarities differences between these disorders, we undertook a multicenter international of one largest case series (CNL, n = 24; aCML, 37 cases, respectively), focusing on mutational profiles (n 53 molecular data) diseases. We found no in presentations or outcomes both entities. As previously described, CNL aCML share...
Mortality rates for COVID-19 have declined over time in the general population, but data patients with hematologic malignancies are contradictory. We identified independent prognostic factors severity and survival unvaccinated malignancies, compared mortality versus non-cancer inpatients, investigated post condition. Data were analyzed from 1166 consecutive, eligible population-based HEMATO-MADRID registry, Spain, prior to vaccination roll-out, stratified into early (February-June 2020; n =...
A greater understanding of clinical trends in COVID-19 outcomes among patients with hematologic malignancies (HM) over the course pandemic, particularly Omicron era, is needed. This ongoing, observational, and registry-based study prospective data collection evaluated severity mortality 1818 adult HM diagnosed between 27 February 2020 1 October 2022, at 31 centers Madrid region Spain. Of these, 1281 (70.5%) 537 (29.5%) were reported pre-Omicron periods, respectively. Overall, aged ≥70 years...
Abstract Background Patients with cancer have been shown to a higher risk of clinical severity and mortality compared non-cancer patients COVID-19. hematologic malignancies typically are known levels immunosuppression may develop more severe respiratory viral infections than solid tumours. Data on COVID-19 in limited. Here we characterise disease mortality, evaluate potential prognostic factors for mortality. Methods In this population-based registry study, collected de-identified data...
Isolated paresis of the inferior rectus muscle (IRM) represents a rare occurrence. This case report involves young adult male who, abruptly during Valsalva maneuver, encountered acute vertical diplopia due to right IRM paresis, resolving spontaneously within few hours. The patient presented without identifiable risk factors, and magnetic resonance imaging revealed minor left thalamic ischemic lesion. A cardiac study identified presence patent foramen ovale, potentially associated with...
Despite advances in diagnosis of erythrocytosis and thrombocytosis due to driver mutation testing, many cases remain classified as “idiopathic”. This can be explained by the absence an evident secondary cause, inconclusive bone marrow biopsy or neglection family history. Analysis a broad panel genes through next-generation sequencing (NGS) could improve diagnostic work-up identifying underlying genetic causes. We reviewed results NGS performed our laboratory its impact on 117 patients with...